Electrophysiological features of the peripheral neuropathy in patients with pathologic biallelic RFC1 repeat expansions
Muscle & Nerve · 2024
DOI: 10.1002/mus.28257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2024. Verfasst von Claudia Calezis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Referral Centre for Neuromuscular Diseases and ALS, La Timone University Hospital, Aix-Marseille University, Marseille, France. Hauptthemen laut MEDLINE: Neural Conduction, Replication Protein C, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction/Aims Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) is caused by RFC1 expansions. Sensory neuronopathy, polyneuropathy, and involvement of motor, autonomic, and cranial nerves have all been described with RFC1 expansions. We aimed to describe the electrodiagnostic features of patients with RFC1 expansions through multimodal electrophysiological investigations.
Methods
Thirty‐five patients, with a median age of 70 years, and pathologic biallelic repeat expansions in the RFC1 gene, were tested for motor and sensory nerve conduction, flexor carpi radialis (FCR) and soleus H‐reflexes, blink reflex, electrochemical skin conductance, sympathetic skin response (SSR), and heart rate variability with deep breathing (HRV).
Results
Only 16 patients (46%) exhibited the full clinical CANVAS spectrum. Distal motor amplitudes were normal in 30 patients and reduced in the legs of five patients. Distal sensory amplitudes were bilaterally reduced in a non‐length dependent manner in 30 patients. Conduction velocities were normal. Soleus H‐reflexes were abnormal in 19/20 patients of whom seven had preserved Achilles reflexes. FCR H‐reflexes were absent or decreased in amplitude in 13/14 patients. Blink reflex was abnormal in 4/19 patients: R1 latencies for two patients and R2 latencies for two others. Fourteen out of 31 patients (45%) had abnormal results in at least one autonomic nervous system test, either for ESC (12/31), SSR (5/14), or HRV (6/19).
Discussion
Less than half of the patients with RFC1 expansions exhibited the full clinical CANVAS spectrum, but nearly all exhibited typical sensory neuronopathy and abnormal H‐reflexes. Involvement of small nerve fibers and brainstem neurons was less common.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Referral Centre for Neuromuscular Diseases and ALS, La Timone University Hospital, Aix-Marseille University, Marseille, France.
- Department of medical genetic, La Timone University Hospital, Aix-Marseille University, Marseille, France.
- Department of Neurology and Movement Disorders, La Timone University Hospital, Aix-Marseille University, Marseille, France.
ORCID-Profile: Emilien Delmont
Zitieren
APA
Calezis, C., Bonello-Palot, N., Verschueren, A., Azulay, J. P., Fortanier, E., Grapperon, A. M., Kouton, L., Gallard, J., Salort-Campana, E., Attarian, S., & Delmont, E. (2024). Electrophysiological features of the peripheral neuropathy in patients with pathologic biallelic RFC1 repeat expansions. Muscle & Nerve. https://doi.org/10.1002/mus.28257
Vancouver
Calezis C, Bonello-Palot N, Verschueren A, Azulay JP, Fortanier E, Grapperon AM, et al. Electrophysiological features of the peripheral neuropathy in patients with pathologic biallelic RFC1 repeat expansions. Muscle & Nerve. 2024. doi:10.1002/mus.28257
BibTeX
@article{Calezis2024,
author = {Calezis, Claudia and Bonello-Palot, Nathalie and Verschueren, Annie and Azulay, Jean-Philippe and Fortanier, Etienne and Grapperon, Aude-Marie and Kouton, Ludivine and Gallard, Julien and Salort-Campana, Emmanuelle and Attarian, Shahram and Delmont, Emilien},
title = {Electrophysiological features of the peripheral neuropathy in patients with pathologic biallelic RFC1 repeat expansions},
journal = {Muscle & Nerve},
year = {2024},
doi = {10.1002/mus.28257}
}
EUVIMED